Karyopharm Therapeutics
KPTI
KPTI
88 hedge funds and large institutions have $415M invested in Karyopharm Therapeutics in 2018 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 39 increasing their positions, 21 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
88
Holders Change
-2
Holders Change %
-2.22%
% of All Funds
2.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
39
Reduced
21
Closed
14
Calls
$2.65M
Puts
$2.7M
Net Calls
-$54K
Net Calls Change
-$1.01M
Top Buyers
| 1 |
Millennium Management
New York
|
+$11.2M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$10.3M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
+$7.52M |
| 4 |
State Street
Boston,
Massachusetts
|
+$5.36M |
| 5 |
DAM
Doheny Asset Management
Los Angeles,
California
|
+$3.07M |
